Literature DB >> 12736261

Circular permutation of 5-aminolevulinate synthase: effect on folding, conformational stability, and structure.

Anton V Cheltsov1, Wayne C Guida, Gloria C Ferreira.   

Abstract

The first and regulatory step of heme biosynthesis in mammals begins with the pyridoxal 5'-phosphate-dependent condensation reaction catalyzed by 5-aminolevulinate synthase. The enzyme functions as a homodimer with the two active sites at the dimer interface. Previous studies demonstrated that circular permutation of 5-aminolevulinate synthase does not prevent folding of the polypeptide chain into a structure amenable to binding of the pyridoxal 5'-phosphate cofactor and assembly of the two subunits into a functional enzyme. However, while maintaining a wild type-like three-dimensional structure, active, circularly permuted 5-aminolevulinate synthase variants possess different topologies. To assess whether the aminolevulinate synthase overall structure can be reached through alternative or multiple folding pathways, we investigated the guanidine hydrochloride-induced unfolding, conformational stability, and structure of active, circularly permuted variants in relation to those of the wild type enzyme using fluorescence, circular dichroism, activity, and size exclusion chromatography. Aminolevulinate synthase and circularly permuted variants folded reversibly; the equilibrium unfolding/refolding profiles were biphasic and, in all but one case, protein concentration-independent, indicating a unimolecular process with the presence of at least one stable intermediate. The formation of this intermediate was preceded by the disruption of the dimeric interface or dissociation of the dimer without significant change in the secondary structural content of the subunits. In contrast to the similar stabilities associated with the dimeric interface, the energy for the unfolding of the intermediate as well as the overall conformational stabilities varied among aminolevulinate synthase and variants. The unfolding of one functional permuted variant was protein concentration-dependent and had a potentially different folding mechanism. We propose that the order of the ALAS secondary structure elements does not determine the ability of the polypeptide chain to fold but does affect its folding mechanism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12736261     DOI: 10.1074/jbc.M207011200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Conversion of 5-aminolevulinate synthase into a more active enzyme by linking the two subunits: spectroscopic and kinetic properties.

Authors:  Junshun Zhang; Anton V Cheltsov; Gloria C Ferreira
Journal:  Protein Sci       Date:  2005-05       Impact factor: 6.725

2.  High-resolution structure prediction of a circular permutation loop.

Authors:  Bruno E Correia; Margaret A Holmes; Po-Ssu Huang; Roland K Strong; William R Schief
Journal:  Protein Sci       Date:  2011-09-30       Impact factor: 6.725

3.  Functional asymmetry for the active sites of linked 5-aminolevulinate synthase and 8-amino-7-oxononanoate synthase.

Authors:  Tracy D Turbeville; Junshun Zhang; W Christopher Adams; Gregory A Hunter; Gloria C Ferreira
Journal:  Arch Biochem Biophys       Date:  2011-05-11       Impact factor: 4.013

4.  Folding pathway of the pyridoxal 5'-phosphate C-S lyase MalY from Escherichia coli.

Authors:  Mariarita Bertoldi; Barbara Cellini; Douglas V Laurents; Carla Borri Voltattorni
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

5.  Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans.

Authors:  Isabel Astner; Jörg O Schulze; Joop van den Heuvel; Dieter Jahn; Wolf-Dieter Schubert; Dirk W Heinz
Journal:  EMBO J       Date:  2005-08-25       Impact factor: 11.598

Review 6.  Vitamin B6: a long known compound of surprising complexity.

Authors:  Sutton Mooney; Jan-Erik Leuendorf; Christopher Hendrickson; Hanjo Hellmann
Journal:  Molecules       Date:  2009-01-12       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.